Clinical trial

BAY86-5046 (Betaseron), Non Interventional Studies

NCT02121444

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2014-06-23

PhaseN/A

Study timeline

Study start (actual)2014-06-23Date precision: day

Registry last updated2017-10-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisverified · MONDO: multiple sclerosis

Interventions

Interferon beta-1b (Betaferon, BAY 86-5046)DRUG

BETACONNECT auto-injector.DEVICE

Sponsors & collaborators

Bayerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02121444 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.